DR. REDDY’S LABORATORIES LIMITED Restricted Cash And Cash Equivalents
DR. REDDY’S LABORATORIES LIMITED (RDY) had Restricted Cash And Cash Equivalents of INR 544.00 million as of 2025-03-31, per its 20-F filed 2025-06-06.
Financial Statements › Notes
ifrs-full:RestrictedCashAndCashEquivalents · last filed 2025-06-06
- 2025-03-31: Restricted Cash And Cash Equivalents 544.00M INR.
- 2024-03-31: Restricted Cash And Cash Equivalents 300.00M INR; Restricted Cash And Cash Equivalents as first filed 213.00M INR.
- 2023-03-31: Restricted Cash And Cash Equivalents 73.00M INR.
- 2022-03-31: Restricted Cash And Cash Equivalents 72.00M INR.
| Period end | Restricted Cash And Cash Equivalents | Restricted Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-03-31 | 544.00M INR 20-F · filed 2025-06-06 | |
| 2024-03-31 | 300.00M INR 20-F · filed 2025-06-06 | 213.00M INR 20-F · filed 2024-06-12 |
| 2023-03-31 | 73.00M INR 20-F · filed 2024-06-12 | |
| 2022-03-31 | 72.00M INR 20-F · filed 2023-06-13 | |
| 2021-03-31 | 82.00M INR 20-F · filed 2022-06-27 | |
| 2020-03-31 | 15.00M INR 20-F · filed 2021-06-30 | |
| 2019-03-31 | 12.00M INR 20-F · filed 2020-06-15 | |
| 2018-03-31 | 14.00M INR 20-F · filed 2019-06-03 | 86.00M INR 20-F · filed 2018-07-12 |
| 2017-03-31 | 177.00M INR 20-F · filed 2018-07-12 |